These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 28121396)

  • 1. Investigation of the Subcellular Neurotoxicity of Amyloid-β Using a Device Integrating Microfluidic Perfusion and Chemotactic Guidance.
    Li W; Xu Z; Xu B; Chan CY; Lin X; Wang Y; Chen G; Wang Z; Yuan Q; Zhu G; Sun H; Wu W; Shi P
    Adv Healthc Mater; 2017 Apr; 6(7):. PubMed ID: 28121396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of YFP to study amyloid-beta associated neurite alterations in live brain slices.
    Brendza RP; Simmons K; Bales KR; Paul SM; Goldberg MP; Holtzman DM
    Neurobiol Aging; 2003 Dec; 24(8):1071-7. PubMed ID: 14643378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Axonal amyloid precursor protein and its fragments undergo somatodendritic endocytosis and processing.
    Niederst ED; Reyna SM; Goldstein LS
    Mol Biol Cell; 2015 Jan; 26(2):205-17. PubMed ID: 25392299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyloid-β and tau--a toxic pas de deux in Alzheimer's disease.
    Ittner LM; Götz J
    Nat Rev Neurosci; 2011 Feb; 12(2):65-72. PubMed ID: 21193853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. β-amyloid induces a dying-back process and remote trans-synaptic alterations in a microfluidic-based reconstructed neuronal network.
    Deleglise B; Magnifico S; Duplus E; Vaur P; Soubeyre V; Belle M; Vignes M; Viovy JL; Jacotot E; Peyrin JM; Brugg B
    Acta Neuropathol Commun; 2014 Sep; 2():145. PubMed ID: 25253021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amyloid-β and tau: the trigger and bullet in Alzheimer disease pathogenesis.
    Bloom GS
    JAMA Neurol; 2014 Apr; 71(4):505-8. PubMed ID: 24493463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracellular amyloid-β accumulation in calcium-binding protein-deficient neurons leads to amyloid-β plaque formation in animal model of Alzheimer's disease.
    Moon M; Hong HS; Nam DW; Baik SH; Song H; Kook SY; Kim YS; Lee J; Mook-Jung I
    J Alzheimers Dis; 2012; 29(3):615-28. PubMed ID: 22269161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloid beta from axons and dendrites reduces local spine number and plasticity.
    Wei W; Nguyen LN; Kessels HW; Hagiwara H; Sisodia S; Malinow R
    Nat Neurosci; 2010 Feb; 13(2):190-6. PubMed ID: 20037574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Docosahexaenoic acid withstands the Aβ(25-35)-induced neurotoxicity in SH-SY5Y cells.
    Hashimoto M; Katakura M; Hossain S; Rahman A; Shimada T; Shido O
    J Nutr Biochem; 2011 Jan; 22(1):22-9. PubMed ID: 20226652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual-specificity phosphatase 26 (DUSP26) stimulates Aβ42 generation by promoting amyloid precursor protein axonal transport during hypoxia.
    Jung S; Nah J; Han J; Choi SG; Kim H; Park J; Pyo HK; Jung YK
    J Neurochem; 2016 Jun; 137(5):770-81. PubMed ID: 26924229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plaque formation and the intraneuronal accumulation of β-amyloid in Alzheimer's disease.
    Takahashi RH; Nagao T; Gouras GK
    Pathol Int; 2017 Apr; 67(4):185-193. PubMed ID: 28261941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphorylation of the amyloid β-peptide at Ser26 stabilizes oligomeric assembly and increases neurotoxicity.
    Kumar S; Wirths O; Stüber K; Wunderlich P; Koch P; Theil S; Rezaei-Ghaleh N; Zweckstetter M; Bayer TA; Brüstle O; Thal DR; Walter J
    Acta Neuropathol; 2016 Apr; 131(4):525-37. PubMed ID: 26898910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PDAPP; YFP double transgenic mice: a tool to study amyloid-beta associated changes in axonal, dendritic, and synaptic structures.
    Brendza RP; O'Brien C; Simmons K; McKeel DW; Bales KR; Paul SM; Olney JW; Sanes JR; Holtzman DM
    J Comp Neurol; 2003 Feb; 456(4):375-83. PubMed ID: 12532409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abeta associated neuropil changes: correlation with neuronal loss and dementia.
    Knowles RB; Gomez-Isla T; Hyman BT
    J Neuropathol Exp Neurol; 1998 Dec; 57(12):1122-30. PubMed ID: 9862634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BACE overexpression alters the subcellular processing of APP and inhibits Abeta deposition in vivo.
    Lee EB; Zhang B; Liu K; Greenbaum EA; Doms RW; Trojanowski JQ; Lee VM
    J Cell Biol; 2005 Jan; 168(2):291-302. PubMed ID: 15642747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dendritic and axonal mechanisms of Ca2+ elevation impair BDNF transport in Aβ oligomer-treated hippocampal neurons.
    Gan KJ; Silverman MA
    Mol Biol Cell; 2015 Mar; 26(6):1058-71. PubMed ID: 25609087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural studies of amyloid-β peptides: Unlocking the mechanism of aggregation and the associated toxicity.
    Aleksis R; Oleskovs F; Jaudzems K; Pahnke J; Biverstål H
    Biochimie; 2017 Sep; 140():176-192. PubMed ID: 28751216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accumulation of a repulsive axonal guidance molecule RGMa in amyloid plaques: a possible hallmark of regenerative failure in Alzheimer's disease brains.
    Satoh J; Tabunoki H; Ishida T; Saito Y; Arima K
    Neuropathol Appl Neurobiol; 2013 Feb; 39(2):109-20. PubMed ID: 22582881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropathology and biochemistry of Aβ and its aggregates in Alzheimer's disease.
    Thal DR; Walter J; Saido TC; Fändrich M
    Acta Neuropathol; 2015 Feb; 129(2):167-82. PubMed ID: 25534025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.